Participated · Equity · Aug 2023

AeroSafe Global provides Cold Chain as a Service (CCaaS) for biopharmaceuticals, offering reusable thermal packaging, outsourced supply chain services, and a temperature-monitoring control tower under a pay-per-turn program. Its services are designed to ensure safe, sustainable delivery and effective use of pharmaceuticals. More than 45 biopharma companies use AeroSafe to deliver millions of shipments to hundreds of thousands of patients, providers, pharmacies, and hospital systems across 85 countries. The company is led by CEO Jay McHarg and emphasizes operational scale and sustainability in its offering. Following the recent financing, AeroSafe plans to invest in product development and increased operational capacities to support continued customer growth. The article reports a $43M financing raised to support these initiatives. AeroSafe Global provides end-to-end cold-chain-as-a-service (CCaaS) combining proprietary temperature-controlled packaging with supply chain management, data tracking and analytics. Its cost-efficient reuse model and temperature reliability are used by pharmaceutical, biopharmaceutical, specialty pharmacy and medical device customers, including 12 of the top 20 global pharmaceutical companies. Many COVID-19 vaccines and treatments are currently being delivered using AeroSafe’s products and services. The company touts a guarantee of zero temperature excursions and reports its reuse model reduces customer greenhouse gas emissions by 40 million pounds per year. AeroSafe will use new capital to support value-added services and technologies and to further expand into new geographies. Comerica Bank expanded the company’s borrowing capacity as part of the financing. AeroSafe Global provides cold-chain-as-a-service (CCaaS) with proprietary packaging technology, a cost-efficient reuse business model, and data tracking and analytics to ensure safe, temperature-controlled delivery of drugs and devices. The company serves more than 30 Fortune 500 pharmaceutical and healthcare customers and guarantees zero temperature excursions across a range of shipping situations. Based in Rochester, New York, AeroSafe combines patented technology with a logistics platform to offer turnkey cold chain solutions from manufacturer to end-user. The company announced an aggregate $31.5 million growth capital investment to accelerate sales and marketing, launch additional value-added services and technologies, and expand into new geographies. AeroSafe emphasizes sustainability through its reusable packaging model and positions itself as a technology-based service partner rather than a vendor. Management says the funds will support industry adoption and continued innovation to meet evolving cold-chain needs. American Aerogel Corporation develops, produces and sells Aerocore, an aerogel-based insulation product used notably in shipping temperature-sensitive biomedical and pharmaceutical goods. The product is designed to increase energy efficiency, reduce deterioration of shipped goods and cut shipping and transportation costs. The company is expanding its market by developing insulation products specifically for refrigerated trucks and intermodal containers. Led by General Manager Jay McHarg, the firm manufactures its insulation products in Rochester, N.Y. In September 2011 the company received new external financing to support growth and manufacturing expansion. Cycle Capital Management will also support the company through its industry network and cleantech growth experience.

Led · Series A · May 2023

MayMaan Research is a Hollywood, Florida–based clean energy and power-generation technology company led by CEO Doron Shmueli and President Eitan Shmueli. Its core product family includes AquaStroke®, a technology that runs on a fuel composed of 70% water and 30% ethanol to enable cleaner combustion for engines and generators. The company says the water-ethanol fuel eliminates the need for traditional gasoline or diesel while reducing emissions and costs. MayMaan intends to use the proceeds from its recent financing to accelerate development and deployment of its clean energy solutions. The article identifies the company as pursuing deployment of its technologies to scale impact on emissions and operating costs.

Led · Series B · Mar 2023

Intelligent fluids develops non-toxic, skin-friendly cleaning solutions for industrial and professional use. Led by CEO Christian Römlein, its cleaners serve sectors from oil and gas and LED displays to adhesive removal and microelectronics. The products are designed to combine cleaning efficiency with ecological safety for use in production, trade, crafts and households. The company raised €10m in a Series B financing to support operational growth. It plans to use the funds to grow the team and increase manufacturing capacity at its German plant, and to initiate global expansion by establishing manufacturing entities in the USA, India, MENA and Taiwan.

Led · Series B · Feb 2023

QiO Technologies develops the Foresight Sustainability Suite™, an industrial IoT AI software product that collects operational data and implements real-time actions to optimize energy efficiency and reduce GHG emissions. Its suite has delivered up to 20% savings on energy and maintenance costs and reduced GHG emissions by up to 10%; the Foresight Optima DC+™ product (developed with Intel) has delivered 20–30% energy and emissions reductions in data centers. The platform also automates real-time ESG reporting, enabling customers to track Scope 1 and Scope 2 emissions. QiO will use the new funding to expand operations in the USA and Europe, enhance the capabilities of its Foresight Sustainability Suite™, and accelerate customer acquisition in hard-to-abate sectors such as automotive, steel, cement, oil & gas, data centers and telecoms. The company is headquartered in the UK with engineering and delivery teams in India supporting global customers.

Led · Series A · Mar 2022

Novolyze develops patented digital solutions that digitalize food safety and quality processes, offering dynamic monitoring, traceability, and holistic views of process control, sanitation control, and environmental monitoring. Its platform is used by 20 of the world’s top 100 food companies, including Nestlé, MARS, ADM, Cargill, and Olam, to mitigate risks, ensure compliance, augment plant performance, and increase sustainability. The company says its solutions can also help customers decrease energy and water use and reduce carbon footprint. Novolyze plans to use new funding to hire additional employees and accelerate feature enhancements to its digitalized solutions for Environmental Monitoring, Process Control, and Sanitation Control. The company has grown its presence in the U.S., France, and Serbia and was founded in 2012. The business emphasizes replacing inefficient manual, paper-based processes to improve efficiency, scale, and sustainability for food manufacturers. Novolyze produces powdered, ready-to-use non‑pathogenic microorganisms that mimic common foodborne pathogens (salmonella, listeria, E. coli) so manufacturers can validate processes like baking, pasteurization, extruding and drying without bringing pathogens into facilities. The surrogates are designed to reduce the cost and logistical burden of validation — Novolyze claims a 70% reduction in overall validation cost and eliminates the need for on-site consultant preparations. The company has contracts with ten major global food players and is running a pilot with Australia’s GrainCorp through the Terra Accelerator. Novolyze operates in France and the United States with offices in Dijon, San Francisco, and Cambridge, MA; the company was founded in 2012. Management said it expects roughly €1 million in revenue in 2018. Using the new funding, Novolyze plans to expand market share in Europe, the US, and Asia and to launch a digital product for verification of food safety processes in mid‑2018.